Dr. David Briscoe
Harvard Medical School, Boston, USA |
Vascular Endothelial Growth Factor in Acute and Chronic Rejection |
Dr. Ginny Bumgardner
Ohio State University, Columbus, USA |
Analysis of a Novel Strategy which Suppresses Aggressive (CD4-Independent) CD8+ T-Cell-Initiated Hepatocyte Rejection |
Dr. Juan Contreras
University of Alabama, Birmingham, USA |
Increase of Islet Engraftment by Mobilizing Bone-Marrow-Derived Endothelial Progenitor Cells |
Prof. Philip Halloran
University of Alberta, Edmonton, Canada |
Mechanisms of Renal Allograft Rejection |
Prof. John Kirby
University of Newcastle, Newcastle upon Tyne, UK |
Therapeutic Elimination of Intraepithelial T Cells: A Strategy to Reduce Epithelial-Mesenchymal Transdifferentiation and Chronic Allograft Dysfunction |
Dr. Wei-Ping Min
University of Western Ontario, London, Canada |
Novel Strategy for Inducing Transplant Tolerance by Genetically Modifying Dendritic Cells with siRNA |
Dr. Jeffrey Schechner
Yale University School of Medicine, New Haven, USA |
Vascularization of Engineered Human Skin Equivalents |
Prof. Ann Simpson
University of Technology, Sydney, Australia |
Correction of Diabetes Using Insulin-Secreting Liver Cells |
Dr. Peter Terness
University of Heidelberg, Heidelberg, Germany |
Using the Immunosuppressive IDO Gene for Prevention of Allograft Rejection |
